NANOLЕК Completes Fourth Stage of Pentaxim Vaccine Supplies under Government Contract Ahead of Schedule 18.08.2026
Nanolek and Alphamab have entered into an agreement to launch a drug for the prevention of bleeding in hemophilia patients across Eurasian countries. 17.06.2026
Government of the Kirov Region and Nanolek Formalize Partnership Through Cooperation Agreement 19.05.2026
Nanolek completes ahead of schedule the next delivery stage of Pentaxim vaccine under state contract 13.04.2026
Russian Clinical Experience with Innovative Hunter Syndrome Therapy Presented at Conference in Tokyo 23.03.2026
Development of the Biopharmaceutical Cluster of the Kirov Region Discussed at Nanolek’s Production Site 27 February 2026, Moscow 27.02.2026
Nanolek Ranks Among the Top 20 Largest Taxpayers of the Kirov Region for the Fifth Consecutive Year 30.01.2026
Nanolek Recognized as a Winner of the National Industrial Technology Award “Priority — 2025” 26.11.2025
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine 29.10.2025
The results of a clinical trial of the first Russian HPV vaccine were presented to the medical community 11.06.2025
Nanolek celebrated its birthday by organising a sports festival for the residents of Lyovintsevo 16.05.2025
Evgeny Barinov takes part in the forum for leaders, CEOs, and HR directors “The New Reality of Management” 28.04.2025
The Russian Ministry of Health authorised a phase III clinical trial of a new pneumococcal vaccine 11.04.2025
Nanolek received a registration certificate for the first Russian vaccine against human papillomavirus 31.03.2025
The director of occupational health and industrial safety at Nanolek entered the Top 20 HSE managers 16.12.2024
A joint educational project of the Nanolek company and Vyatka State University has started 12.12.2024
Sber Pro: Alexey Pavlov, Director of BMC Nanolek, Discusses Biotechnology Development in Russia 11.06.2024
Nanolek’s Vaccines Recognized as Some of the Top Products of the Year in the Platinum Ounce Competition 18.04.2024
Vademecum: “Nanolek Already Achieved Sustainable Development Under Khristenko.” Where’s the Vaccine Manufacturer Headed After Founder’s Departure? 14.06.2023
The Ministry of Education of the Kirov Region, Vyatka State University and Nanolek Sign a Cooperation Agreement 22.03.2022
Nanolek teams up with Sanofi to produce the first batch of meningococcal vaccines at the plant in the Kirov region 10.03.2022
The Kirov region launches the production of CoviVac vaccines. By year-end, 250 thousand doses are expected to be produced 17.12.2021
Safer and More Well-Tolerated: Comparison of the First Russian HPV Vaccine to Its American Peer 22.11.2021
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma 21.10.2021
Maxim Stetsyuk Takes Part in the Forbes Conference “Sustainable Healthcare, Investments, Technologies, and Management” 08.10.2021
Sanofi Pasteur and Nanolek Sign an Agreement on Domestic Production of Meningitis Vaccines to Produce up to 3.5 Million Doses Annually in Russia Starting From 2022 04.10.2021
New Vaccines Are Created Here: The Nanolek R&D Centre Opens Up in Pushchino — a Science City Near Moscow 20.09.2021
Nanolek to allocate 10 million rubles for support of a cardiology center in the Kirov region 02.08.2021
Maxim Stetsyuk, First Deputy General Director of Nanolek, speaks at the conference on COVID-19 organized by the All-Russian Union of Patients 02.08.2021
Vladimir Khristenko, President of Nanolek, attends the Trust Summit organized by Boston Consulting Group 29.07.2021
Developers of medical products for the treatment of sepsis and severe forms of COVID-19 raise 200 million rubles in investment for development purposes 08.07.2021
16,000 locally produced packages of a drug to treat multiple myeloma launched on the Russian market 02.07.2021
Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib 18.06.2021
President of Nanolek Vladimir Khristenko signs the Declaration of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union) at the Forum in St. Petersburg 02.06.2021
The plant of Nanolek in Kirow Region is about to launch production of the third CoviVac vaccine 26.05.2021
Nanolek will invest 5 billion rubles in the full production cycle and proprietary vaccine development by 2024 to become a leader in Russia’s vaccine market 19.05.2021
At a Meeting with Russian President Vladimir Putin on March 22, Nanolek Confirms Its Plans to Produce 5 Mln Doses of CoviVac Vaccine by the End of 2021 22.03.2021
Mikhail Nekrasov, CEO of NANOLEK, attends the XVI Annual Conference “Pharmaceutical Business in Russia” 15.03.2021
Maxim Stetsyuk, First Deputy General Director of Nanolek, takes part in the scientific conference on COVID-19 12.03.2021
Marina Mazurevskaya, Deputy CEO for Legal Affairs and Government Relations Speaks at GR FORCE 2021 GR Director Forum 04.03.2021
Svetlana Zakirova, Deputy CEO for Development and Research at NANOLEK, delivered a speech at Pharma’s cool in Skolkovo 03.03.2021
Vladimir Khristenko, President of NANOLEK, takes part in the VIII Conference on Strategic Cooperation between Russia and Germany-2021 17.02.2021
Yulia Deeva, Director of Corporate Communications at NANOLEK, takes part in the V All-Russian Forum of PR Directors 15.02.2021
SKOLKOVO residents NANOLEK and Efferon sum up the results of work with Extracorporeal Blood Purification Devices: Efferon LPS and Efferon CT 03.02.2021
NANOLEK Ranks First in the Top Fast Growing Companies of the TechUspech-2020 Rating for the Second Year in a Row 01.02.2021
Biopharmaceutical Company NANOLEK Receives a Registration Certificate for the Vaccine Outside of Russia for the First Time 13.01.2021
The round table 'Immunoprophylaxis as a Shared Concern of the People and the State' brought together a wide range of contributors to find out how to build a meaningful dialogue with different population groups 17.12.2020
Top manager of NANOLEK speaks about the pharmacoeconomics of innovative drugs for the treatment of genetic and orphan diseases 15.12.2020
Vladimir Khristenko, President of NANOLEK hits the list of Russia’s top young economic leaders for the second year in a row 14.12.2020
Experts in Kirov sum up the results of work and prospects for the development of biopharmaceutical and biotechnological industries in the Kirov region 12.12.2020
General Director of NANOLEK Takes Part in the XII All-Russian Congress of Pharmaceutical and Medical Industry Workers 08.12.2020
The Director of the Department of Economic Territory Development at NANOLEK shares his experience in managing innovative projects and research with businessmen of the Kirov region 28.11.2020
The General Director of NANOLEK takes part in the round table discussion “Current approaches to solving reproductive health problems” 27.11.2020
On November 19, the “My business” Сenter hosted a round table discussion to dwell on issues relating to interaction between businesses and support infrastructure in the biotechnological sector 19.11.2020
Experts of NANOLEK took part in the round table discussion “Early diagnosis and multidisciplinary approach are the key to high quality of life for patients with mucopolysaccharidosis” 16.11.2020
NANOLEK’s Director of the Department for Development of Economic Territories — A Participant of the Round Table Talk: Certification of Products by Biotechnological Enterprises 11.11.2020
NANOLEK presents medical devices for extracorporeal blood detoxification at the forum “Issues of Urgent Cardiology-2020” 11.11.2020
Maxim Stetsyuk, Executive Director of NANOLEK, participant of the forum “COVID-19: vaccination and immunization” 02.11.2020
NANOLEK’s General Director Takes Part in the INNOPROM Session: Innovations in Pharmaceuticals and Medicine: Overcoming Barriers in the Development and Creation of Solutions 27.10.2020
Participants of the “Open innovations” Forum discussed the issues of vaccine production and prevention 22.10.2020
The Federal Center status may be granted to the Research and Educational Center “Biopolis” 21.10.2020
The chairman of the Board of AFPEES (Association of Pharmaceutical Manufacturers of the Eurasian Economic Union) took part in the plenary session of the V BIOTECHMED–2020 Forum 17.10.2020
Maxim Stetsyuk, Executive Director at NANOLEK, takes part in the business program of the V Forum “Biotechmed” 15.10.2020
Representatives of NANOLEK discussed the issues related to quality, measures to counteract counterfeit and forged medications 09.10.2020
Sergey Tolstobrov, Director of the Department of Economic Territory Development at NANOLEK, takes part in the event organized by the Vyatka Chamber of Commerce and Industry in Kirov 07.10.2020
NANOLEK is included in the National register of “Leading organizations of industrial infrastructure in Russia” 02.10.2020
Alexey Pavlov, Director of the NANOLEK Quality Management Department, speaker of the V All-Russian GMP conference 01.10.2020
Experts discuss the First Efforts in implementing the Immunoprophylaxis Strategy until 2035 29.09.2020
Yulia Deeva, Director of Corporate Communications at NANOLEK — speaker at Mediasreda held by Interfax 23.09.2020
The Executive Director of NANOLEK Takes Part in the 12th International Conference “What is Happening in the Pharmaceutical Market?” 15.09.2020
NANOLEK supports the IX online school of the Federation of Anesthesiologists and Resuscitators of Russia (FAR) 23.08.2020
Mikhail Nekrasov, CEO of NANOLEK, participates in the discussion session “Immunoprophylaxis during the pandemic” 12.08.2020
NANOLEK participates in the All-Russian forum “Health of the nation — the basis of Russia’s prosperity” (ZNOPR) 11.08.2020
NANOLEK — a Nominee of the Second Stage of the Projects Selection for the Priority-2.0 National Award 05.08.2020
NANOLEK, a member of the Association of pharmaceutical manufacturers of the Eurasian Economic Union, congratulates Stanislav Naumov on his appointment as Chairman of the Association’s Board 03.08.2020
Pyotr Koltypin, Vice-President of Sberbank PJSC, Chairman of the Volga-Vyatka Bank of Sberbank, visited the NANOLEK biomedical complex 29.07.2020
Marina Mazurevskaya, Deputy General Director for Legal Issues and Work with Government Agencies Speaks at GxP Summit 09.07.2020
NANOLEK’s Employees — Vadim Kalinichenko (Chief of Medical Department) and Daria Neverova (Chief of Registration Department) — attended the EAEU PHARMA WEEK 19.06.2020
Yulia Deeva, Director for Corporate Communications at NANOLEK, a participant in the event of the Russian Managers Association “Contours of Managerial Professions in a New Reality” 18.06.2020
NANOLEK was given a market authorization by the Ministry of Health of the Republic of Belarus for the socially significant drug “Hunterase” 17.06.2020
General Director of NANOLEK — Mikhail Nekrasov — Takes Part in the ADVANTIX PHARMA VIRTUAL PLATFORM Virtual Farm Marathon 10.06.2020
Mikhail Nekrasov, General Director, NANOLEK, supports construction of a sports ground in the village of Ugor 07.06.2020
Yulia Deeva, Head of Сorporate Сommunications at NANOLEK, live on the Echo of Moscow radio, Kirov 05.06.2020
NANOLEK provides charity support to regional medical institutions and patient organizations during the epidemic 04.06.2020
NANOLEK and Sanofi Enter a New Stage of Localization of a Five-component Combined Pediatric Vaccine 29.05.2020
CANCER Can Be Prevented: NANOLEK and Combiotech NPK Announce the Start of a Joint Project to Develop and Market First Fully Domestic Vaccine against Human Papillomavirus 26.05.2020
Maxim Stetsyuk, Executive Director of NANOLEK, a speaker at the online-conference The Economy of the Virus. Pharmaceutical Market at the Forefront 21.05.2020
Danail Donchev is appointed Director of the NANOLEK biomedical complex located in Kirov Oblast 29.04.2020
Adsorption columns for the treatment of severe complications of viral pneumonia were delivered to the Clinic of Moscow State University, which was opened by Sobyanin and Sadovnichy 23.04.2020
Participants of the Moscow Innovation Cluster donate medical devices to the hospital in Kommunarka to treat complications in COVID-19 patients 16.04.2020
Address of the Company’s management to employees: NANOLEK is among the companies that take urgent action in emergency situations 27.03.2020
Information letter for partners to notify of NANOLEK’s adherence to normal business practice 19.03.2020
Evgeniy Barinov — speaker at the Forum of Chief Financial Officers — 2020 “CFO of the future: partner, mentor, strategist” 13.02.2020
Vadim Kalinichenko, Director of the NANOLEK Medical Department, about immunity, vaccines and homo sapiens fighting for the right to have a long life 31.01.2020
This is a typical day in the life of our colleague: Irina Chernitsyna, Warehouse Manager of NANOLEK Biomedical Facility 28.01.2020
NANOLEKblog: Elena Stukun, Director of NANOLEK Sales Department, speaks out on the productive work, factors of success and an ideal sales department employee 22.01.2020
Maksim Stetsyuk is a speaker in the course of the discussion Cell and Genetic Technologies Development in Russia at the Gaidar Forum 15.01.2020
NANOLEK was ranked first in the category Fast Growing Major Companies rating TEKHUSPEKH 2019 15.01.2020
The First Step of Pentaxim® Vaccine Delivery Under a 2-year Contract Successfully Completed: a New Era in Fighting Against Dangerous Infections 19.12.2019
Merck joins forces with NANOLEK to launch a production facility in Russia that is expected to produce the most commonly used drugs for cardiovascular diseases 11.12.2019
Mikhail Nekrasov — A Nominee of the Annual Prize “Person of the Year 2019. Large Business and Social Sector” 06.12.2019
Workshop “Shaping the future of the pharmaceutical industry. Trends, Developments and Best practices” 14.11.2019
Setting up production of meningococcal vaccine: new opportunities to protect russian children 14.11.2019
NANOLEK at the IX International partnering forum “Life Sciences Invest. Partnering Russia” 07.11.2019
The delegation of NANOLEK participates in the annual meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) 06.11.2019
'Pharmaceutical Market Promotion of the Eurasian Economic Union' Conference funded by NANOLEK 29.10.2019
JANSSEN AND NANOLEK LAUNCH A PROJECT TO LOCALIZE DARZALEX® FOR THE TREATMENT OF MULTIPLE MYELOMA 24.10.2019
NANOLEK REPRESENTATIVES TOOK PART IN A BUSINESS VISIT TO TURKEY AS PART OF THE GOVERNMENT DELEGATION OF THE KIROV REGION 17.10.2019
NANOLEK is participant of the XI International Conference “What is happening on the pharmaceutical market?” 07.10.2019
Geneticists discussed modern approaches to the treatment of orphan disease at the scientific and practical seminar “Type II mucopolysaccharidosis. Modern approaches to therapy — a specialist’s view” 03.10.2019
NANOLEK is a partner of the All-Russian competition of the Dynamo society in sambo and combat sambo 02.10.2019
